Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 12 04:00PM ET
11.84
Dollar change
-0.17
Percentage change
-1.42
%
IndexRUT P/E- EPS (ttm)-0.07 Insider Own0.30% Shs Outstand130.62M Perf Week-1.74%
Market Cap1.55B Forward P/E26.59 EPS next Y0.45 Insider Trans-18.85% Shs Float130.22M Perf Month-2.71%
Income-6.39M PEG- EPS next Q-0.02 Inst Own96.97% Short Float13.80% Perf Quarter-14.76%
Sales232.28M P/S6.66 EPS this Y615.60% Inst Trans-1.82% Short Ratio9.45 Perf Half Y-18.46%
Book/sh4.80 P/B2.47 EPS next Y72.70% ROA-0.64% Short Interest17.97M Perf Year10.65%
Cash/sh5.68 P/C2.08 EPS next 5Y- ROE-1.06% 52W Range10.06 - 15.15 Perf YTD-15.31%
Dividend Est.- P/FCF16.03 EPS past 5Y54.52% ROI-0.73% 52W High-21.85% Beta1.29
Dividend TTM- Quick Ratio12.96 Sales past 5Y239.63% Gross Margin78.40% 52W Low17.69% ATR (14)0.29
Dividend Ex-Date- Current Ratio13.81 EPS Y/Y TTM-102.20% Oper. Margin-14.66% RSI (14)36.69 Volatility1.74% 2.25%
Employees408 Debt/Eq0.41 Sales Y/Y TTM-67.86% Profit Margin-2.75% Recom1.40 Target Price25.40
Option/ShortYes / Yes LT Debt/Eq0.41 EPS Q/Q-99.65% Payout- Rel Volume1.02 Prev Close12.01
Sales Surprise5.46% EPS Surprise100.00% Sales Q/Q-69.87% EarningsFeb 22 AMC Avg Volume1.90M Price11.84
SMA20-2.66% SMA50-5.26% SMA200-12.89% Trades Volume1,941,201 Change-1.42%
Date Action Analyst Rating Change Price Target Change
Feb-01-24Initiated Goldman Neutral $20
Sep-27-22Initiated JMP Securities Mkt Outperform $22
Jan-06-22Resumed Goldman Buy $38
Aug-06-21Initiated Goldman Buy $19
Aug-07-20Reiterated H.C. Wainwright Buy $14 → $12
Aug-03-20Reiterated H.C. Wainwright Buy $12 → $14
Jun-15-20Initiated Evercore ISI Outperform $14
Oct-18-19Initiated H.C. Wainwright Buy $13
Jul-11-19Upgrade Cantor Fitzgerald Neutral → Overweight $20
Feb-27-19Reiterated Cantor Fitzgerald Overweight $32 → $28
Mar-04-24 11:53PM
08:28PM
Feb-27-24 06:54PM
Feb-23-24 10:34AM
06:38AM
08:00PM Loading…
Feb-22-24 08:00PM
05:15PM
04:44PM
04:01PM
Feb-08-24 04:15PM
Jan-08-24 10:58PM
09:00AM
Jan-05-24 08:50AM
03:03AM
Jan-03-24 06:33PM
09:55AM Loading…
Dec-05-23 09:55AM
Nov-24-23 09:40AM
Nov-20-23 05:04PM
Nov-07-23 09:40AM
Nov-04-23 09:02AM
Nov-03-23 12:28PM
10:46AM
05:31AM
Nov-02-23 06:22PM
04:39PM
04:01PM
11:23AM
Nov-01-23 12:03PM
Oct-30-23 10:00AM
Oct-26-23 04:15PM
12:00PM Loading…
12:00PM
10:02AM
Oct-24-23 07:45AM
Oct-19-23 01:15PM
06:32AM
Oct-16-23 09:55AM
08:50AM
Oct-12-23 10:42AM
Oct-11-23 09:24AM
Oct-05-23 05:01AM
Sep-29-23 09:55AM
08:50AM
Sep-28-23 11:18AM
10:48AM
Sep-26-23 11:49AM
Sep-21-23 09:19AM
Sep-20-23 07:51AM
Sep-18-23 09:16AM
Sep-14-23 09:36AM
Sep-12-23 08:26AM
07:54AM
Sep-11-23 12:31PM
08:21AM
Sep-08-23 07:06PM
Sep-07-23 08:43AM
Sep-06-23 04:05PM
09:33AM
Sep-05-23 09:40AM
Sep-04-23 10:51AM
Aug-28-23 09:55AM
Aug-24-23 08:50AM
Aug-22-23 11:56AM
10:18AM
Aug-16-23 01:21PM
Aug-11-23 05:26AM
Aug-10-23 11:50AM
09:55AM
Aug-07-23 03:06PM
Aug-06-23 07:00AM
Aug-04-23 12:53PM
01:00AM
Aug-03-23 06:55PM
05:45PM
04:05PM
Jul-28-23 02:56PM
Jul-27-23 11:19AM
Jul-20-23 04:15PM
Jul-13-23 03:00PM
Jul-12-23 09:55AM
Jun-21-23 08:00PM
Jun-14-23 10:50AM
Jun-13-23 09:07PM
Jun-01-23 07:52PM
May-30-23 04:15PM
May-08-23 04:15PM
May-03-23 09:42AM
May-02-23 10:00PM
05:35PM
04:37PM
04:05PM
Apr-26-23 08:00PM
Apr-18-23 04:15PM
Apr-09-23 08:52AM
Mar-24-23 06:30AM
Mar-19-23 08:56AM
Mar-01-23 04:15PM
Feb-28-23 08:00AM
Feb-26-23 07:30AM
Feb-24-23 01:00PM
09:24AM
Dynavax Technologies Corp. operates as a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel vaccines and immuno-oncology therapeutics. Its product includes HEPLISAV-B, which prevents infection caused by all known subtypes of hepatitis B virus in adults 18 years of age and older. The company was founded by Lawrence M. Lichtenstein, Dennis A. Carson, and Eyal Raz on August 29, 1996 and is headquartered in Emeryville, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Burgess JustinChief Accounting OfficerMar 01 '24Option Exercise10.457,10174,23220,526Mar 04 05:25 PM
Burgess JustinChief Accounting OfficerMar 01 '24Sale12.7820,526262,3220Mar 04 05:25 PM
Janssen RobertSVP and CMOJan 04 '24Option Exercise9.411,50014,11551,425Jan 08 06:48 PM
Janssen RobertSVP and CMOJan 04 '24Sale15.001,50022,50049,925Jan 08 06:48 PM
Novack David FPresident & COOJan 02 '24Option Exercise5.429,00048,78012,187Jan 04 07:04 PM
Novack David FPresident & COOJan 02 '24Sale14.459,000130,0503,187Jan 04 07:04 PM
Novack David FPresident & COODec 01 '23Option Exercise5.4220,000108,40023,187Dec 05 07:12 PM
Novack David FPresident & COODec 01 '23Sale13.5620,000271,2003,187Dec 05 07:12 PM
Novack David FPresident & COONov 03 '23Option Exercise5.4220,000108,40023,187Nov 07 05:16 PM
Novack David FPresident & COONov 03 '23Sale15.0020,000300,0003,187Nov 07 05:16 PM
Novack David FPresident & COONov 01 '23Option Exercise5.4220,000108,40023,187Nov 03 04:32 PM
Novack David FPresident & COONov 01 '23Sale14.1220,000282,4003,187Nov 03 04:32 PM
Janssen RobertSVP and CMOOct 10 '23Option Exercise9.411,75516,51551,680Oct 11 08:53 PM
Janssen RobertSVP and CMOOct 10 '23Sale15.011,75526,34349,925Oct 11 08:53 PM
Novack David FPresident & COOOct 02 '23Option Exercise5.4240,000216,80043,187Oct 04 04:35 PM
Janssen RobertSVP and CMOOct 02 '23Option Exercise9.415,01547,19154,940Oct 03 08:26 PM
Novack David FPresident & COOOct 02 '23Sale14.8840,000595,0003,187Oct 04 04:35 PM
Janssen RobertSVP and CMOOct 02 '23Sale15.035,01575,37549,925Oct 03 08:26 PM
Novack David FPresident & COOSep 01 '23Option Exercise5.4220,000108,40023,187Sep 05 05:05 PM
Novack David FPresident & COOSep 01 '23Sale14.4820,000289,6003,187Sep 05 05:05 PM
Janssen RobertSVP and CMOAug 24 '23Option Exercise9.416005,64650,525Aug 25 06:47 PM
Janssen RobertSVP and CMOAug 24 '23Sale15.026009,01249,925Aug 25 06:47 PM
Janssen RobertSVP and CMOAug 23 '23Option Exercise9.4134,857328,00484,782Aug 24 12:30 PM
Janssen RobertSVP and CMOAug 23 '23Sale15.0134,857523,20449,925Aug 24 12:30 PM
Novack David FPresident & COOAug 08 '23Option Exercise4.4140,000176,55043,187Aug 10 11:57 AM
Janssen RobertSVP and CMOAug 08 '23Option Exercise9.412,60024,46652,525Aug 09 07:26 PM
Hack Andrew A. F.DirectorAug 08 '23Sale14.391,500,00021,585,000915,000Aug 10 04:31 PM
Novack David FPresident & COOAug 08 '23Sale14.8740,000594,9003,187Aug 10 11:57 AM
Janssen RobertSVP and CMOAug 08 '23Sale15.052,60039,13049,925Aug 09 07:26 PM
Burgess JustinChief Accounting OfficerAug 07 '23Option Exercise8.168,06165,7678,061Aug 08 04:23 PM
Burgess JustinChief Accounting OfficerAug 07 '23Sale14.548,061117,2470Aug 08 04:23 PM
Hack Andrew A. F.DirectorJun 14 '23Sale12.68500,0006,340,0002,415,000Jun 16 04:30 PM
Hack Andrew A. F.DirectorMay 18 '23Sale10.551,000,00010,550,0002,915,000May 19 04:30 PM
Novack David FPresident & COOMay 04 '23Sale10.9017,515190,9143,187May 05 08:58 PM